Precigen (PGEN) Shareholder's Equity (2011 - 2026)
Precigen (PGEN) Shareholder's Equity (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
502.95 Mn |
| 10 |
Precigen |
1.27 Bn |
1.27 Bn |
20.69 Mn |
20.24 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
20.24 Mn |
| Dec 31, 2025 |
20.91 Mn |
| Sep 30, 2025 |
41.87 Mn |
| Jun 30, 2025 |
-36.78 Mn |
| Mar 31, 2025 |
-14.06 Mn |
| Dec 31, 2024 |
38.51 Mn |
| Sep 30, 2024 |
55.38 Mn |
| Jun 30, 2024 |
43.17 Mn |
| Mar 31, 2024 |
97.02 Mn |
| Dec 31, 2023 |
118.50 Mn |
| Sep 30, 2023 |
147.68 Mn |
| Jun 30, 2023 |
166.21 Mn |
| Mar 31, 2023 |
184.13 Mn |
| Dec 31, 2022 |
126.26 Mn |
| Sep 30, 2022 |
142.53 Mn |
| Jun 30, 2022 |
55.65 Mn |
| Mar 31, 2022 |
73.84 Mn |
| Dec 31, 2021 |
107.35 Mn |
| Sep 30, 2021 |
131.25 Mn |
| Jun 30, 2021 |
159.20 Mn |
